Position in CDXS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$294,906
+$10,326 QoQ
Shares Held
180,925
+3.6% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,080,078,438 across 259 Biotechnology names. CDXS ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in CDXS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $294,906 | 180,925 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $284,580 | 174,590 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $300,450 | 123,136 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $234,429 | 96,078 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $181,431 | 67,447 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $160,895 | 33,731 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $102,575 | 33,304 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $95,346 | 30,757 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $342,654 | 98,182 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $108,826 | 35,681 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $71,892 | 38,039 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $95,600 | 34,143 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $137,098 | 33,116 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $144,156 | 30,935 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $177,496 | 29,290 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $273,737 | 26,170 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $554,739 | 26,903 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $842,725 | 26,950 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $746,761 | 32,105 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $610,278 | 26,932 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $356,213 | 15,562 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $247,114 | 11,320 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||